DE69305540D1 - Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung - Google Patents

Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung

Info

Publication number
DE69305540D1
DE69305540D1 DE69305540T DE69305540T DE69305540D1 DE 69305540 D1 DE69305540 D1 DE 69305540D1 DE 69305540 T DE69305540 T DE 69305540T DE 69305540 T DE69305540 T DE 69305540T DE 69305540 D1 DE69305540 D1 DE 69305540D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
antibacterial activity
long
compositions containing
aliphatic alcohols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69305540T
Other languages
English (en)
Other versions
DE69305540T2 (de
Inventor
Mose Santaniello
Maria Ornella Tinti
Domenico Misiti
Piero Foresta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69305540D1 publication Critical patent/DE69305540D1/de
Publication of DE69305540T2 publication Critical patent/DE69305540T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69305540T 1992-01-16 1993-01-15 Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung Expired - Lifetime DE69305540T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920027A IT1254135B (it) 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica.

Publications (2)

Publication Number Publication Date
DE69305540D1 true DE69305540D1 (de) 1996-11-28
DE69305540T2 DE69305540T2 (de) 1997-03-06

Family

ID=11400572

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69305540T Expired - Lifetime DE69305540T2 (de) 1992-01-16 1993-01-15 Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung

Country Status (13)

Country Link
US (2) US5498632A (de)
EP (1) EP0552137B1 (de)
JP (1) JP3294653B2 (de)
KR (1) KR100251888B1 (de)
AT (1) ATE144492T1 (de)
CA (1) CA2087085C (de)
DE (1) DE69305540T2 (de)
DK (1) DK0552137T3 (de)
ES (1) ES2093395T3 (de)
GR (1) GR3021479T3 (de)
HK (1) HK1005724A1 (de)
IT (1) IT1254135B (de)
ZA (1) ZA93162B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1261828B (it) 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US5741816A (en) 1994-06-20 1998-04-21 Tanabe Seiyaku Co., Ltd. Hair-growth agent
IT1274157B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT1274156B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
JPH08133971A (ja) * 1994-09-16 1996-05-28 Toyama Chem Co Ltd 抗ヘリコバクター剤
IT1283955B1 (it) * 1996-03-20 1998-05-07 Sigma Tau Ind Farmaceuti Bis alcanoil esteri della carnitina ad attivita' antibatterica, antimicotica ed antiprotozoaria.
KR100513996B1 (ko) * 1996-11-21 2005-12-07 아지노모토 가부시키가이샤 연속발효에의한l-글루탐산의제조방법
US6403124B1 (en) * 1997-04-16 2002-06-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
EP2286794B8 (de) 2003-10-15 2016-06-01 SynCore Biotechnology CO., LTD Verwendung von kationischen liposomen mit paclitacel
AU2004281184C1 (en) * 2003-10-16 2012-01-12 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
AU2006243337B2 (en) 2005-05-04 2011-09-29 Syncore Biotechnology Co., Ltd Method of administering a cationic liposomal preparation comprising paclitaxel
US8168216B2 (en) 2006-03-22 2012-05-01 Medigene Ag Treatment of triple receptor negative breast cancer
EP2394640A1 (de) 2010-05-21 2011-12-14 MediGene AG Verbesserte liposomale Formulierungen von lipophilen Verbindungen
WO2011147926A2 (en) 2010-05-26 2011-12-01 Erik Reimhult Magnetically responsive membrane structures
BR112014022847B1 (pt) 2012-03-16 2022-08-23 Merck Patent Gmbh Lipídios aminoácidos, composição vesicular, e kit
EP2825156B1 (de) 2012-03-16 2017-07-26 Merck Patent GmbH Targeting mit aminosäure-lipiden

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH596147A5 (de) * 1974-09-25 1978-02-28 Lonza Ag
CH588443A5 (de) * 1974-09-25 1977-06-15 Lonza Ag
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1170861B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Ester di mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1191945B (it) * 1986-06-04 1988-03-31 Avantgarde Spa N-alchilammidi della d(+)-carnitina dotate di attivita' antibatterica,procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1235494B (it) * 1987-12-02 1992-09-04 Avantgarde Spa N-alchilammidi della dl e l(-)carnitina dotate di attivita' antibatterica, procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1231751B (it) * 1989-04-12 1991-12-21 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.

Also Published As

Publication number Publication date
EP0552137A3 (en) 1993-10-20
ATE144492T1 (de) 1996-11-15
US5498633A (en) 1996-03-12
KR100251888B1 (ko) 2000-05-01
EP0552137B1 (de) 1996-10-23
GR3021479T3 (en) 1997-01-31
IT1254135B (it) 1995-09-08
HK1005724A1 (en) 1999-01-22
ITRM920027A1 (it) 1993-07-16
US5498632A (en) 1996-03-12
JP3294653B2 (ja) 2002-06-24
ITRM920027A0 (it) 1992-01-16
KR930016391A (ko) 1993-08-26
ZA93162B (en) 1993-09-30
DE69305540T2 (de) 1997-03-06
EP0552137A2 (de) 1993-07-21
CA2087085A1 (en) 1993-07-17
JPH05339218A (ja) 1993-12-21
DK0552137T3 (da) 1996-11-18
ES2093395T3 (es) 1996-12-16
CA2087085C (en) 2003-12-16

Similar Documents

Publication Publication Date Title
DE69305540D1 (de) Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung
PT90251A (pt) Processo de preparacao de esteres de tetralina de fenois ou de acidos benzoicos e de composicoes farmaceuticas que os contem
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
ZA911728B (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
DE3888415D1 (de) Salpetersäureester-Derivate.
HK1005848A1 (en) Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies
DE69313325D1 (de) Ester von L-Carnitin und Acyl-L-Carnitin, mit entspannender Wirkung, selektiv auf den Gastrointestinaltrakt und sie enthaltende pharmazeutische Zusammensetzungen
ATE43601T1 (de) Phosphorylalkanolamid-derivate von l-carnitin und sie enthaltende arzneimittel.
NO932843D0 (no) Farmasoeytiske preparater
DE3471587D1 (en) Derivatives of benzoic acid, process for their preparation and their use in disinfecting and conserving medicaments
GB2168703B (en) Trienamides
ATE151744T1 (de) Verwendung von estern des acyl-carnitins mit langkettigen aliphatischen alkoholen zur herstellung von pharmazeutischen zusammensetzungen mit antimykotischer wirkung
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
IL82639A0 (en) Transdermal pharmaceutical composition
ATE167056T1 (de) Verwendung von ester von acyl-l-carnitin mit gammahydroxybuttersäure zur behandlung von alkoholismus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 552137

Country of ref document: EP